David Guzo

Array ( [id] => 369766 [patent_doc_number] => 07476539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'DNA containing variant FRT sequences' [patent_app_type] => utility [patent_app_number] => 11/267182 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14967 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476539.pdf [firstpage_image] =>[orig_patent_app_number] => 11267182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5666575 [patent_doc_number] => 20060171925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 11/254926 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16143 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171925.pdf [firstpage_image] =>[orig_patent_app_number] => 11254926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068939 [patent_doc_number] => 20070190040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Recombinant p53 adenovirus methods and compositions' [patent_app_type] => utility [patent_app_number] => 11/251111 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14090 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190040.pdf [firstpage_image] =>[orig_patent_app_number] => 11251111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820516 [patent_doc_number] => 20060024829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Adenovirus packaging cell lines' [patent_app_type] => utility [patent_app_number] => 11/240406 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10826 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024829.pdf [firstpage_image] =>[orig_patent_app_number] => 11240406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887527 [patent_doc_number] => 20060275261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 11/239548 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 12676 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275261.pdf [firstpage_image] =>[orig_patent_app_number] => 11239548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 637746 [patent_doc_number] => 07125720 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'Plasmid maintenance system for antigen delivery' [patent_app_type] => utility [patent_app_number] => 11/229073 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 31504 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 249 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/125/07125720.pdf [firstpage_image] =>[orig_patent_app_number] => 11229073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 619932 [patent_doc_number] => 07141408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-28 [patent_title] => 'Plasmid maintenance system for antigen delivery' [patent_app_type] => utility [patent_app_number] => 11/229069 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 31493 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141408.pdf [firstpage_image] =>[orig_patent_app_number] => 11229069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623159 [patent_doc_number] => 07138112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Plasmid maintenance system for antigen delivery' [patent_app_type] => utility [patent_app_number] => 11/229306 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 32 [patent_no_of_words] => 31488 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 266 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138112.pdf [firstpage_image] =>[orig_patent_app_number] => 11229306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050836 [patent_doc_number] => 20070031381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Recombinant adenoviral vector and method of use' [patent_app_type] => utility [patent_app_number] => 11/228711 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16126 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031381.pdf [firstpage_image] =>[orig_patent_app_number] => 11228711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865051 [patent_doc_number] => 20060099181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Viral vectors having reduced virulence' [patent_app_type] => utility [patent_app_number] => 11/225817 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2139 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099181.pdf [firstpage_image] =>[orig_patent_app_number] => 11225817 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5903272 [patent_doc_number] => 20060046295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Helper virus-free AAV production' [patent_app_type] => utility [patent_app_number] => 11/208901 [patent_app_country] => US [patent_app_date] => 2005-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6207 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046295.pdf [firstpage_image] =>[orig_patent_app_number] => 11208901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880851 [patent_doc_number] => 20060029934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Methods of assessing HIV integrase inhibitor therapy' [patent_app_type] => utility [patent_app_number] => 11/203768 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9489 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029934.pdf [firstpage_image] =>[orig_patent_app_number] => 11203768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590442 [patent_doc_number] => 20060039893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Adenoviral vectors having a protein IX deletion' [patent_app_type] => utility [patent_app_number] => 11/201801 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 16147 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20060039893.pdf [firstpage_image] =>[orig_patent_app_number] => 11201801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912918 [patent_doc_number] => 20060127980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Human excitatory amino acid transporter-2 gene promoter and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/197226 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15458 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127980.pdf [firstpage_image] =>[orig_patent_app_number] => 11197226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769423 [patent_doc_number] => 20050265975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Method for selective inactivation of viral replication' [patent_app_type] => utility [patent_app_number] => 11/195109 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 50597 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20050265975.pdf [firstpage_image] =>[orig_patent_app_number] => 11195109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679560 [patent_doc_number] => 07083981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Method and means for producing high titer, safe, recombinant lentivirus vectors' [patent_app_type] => utility [patent_app_number] => 11/186497 [patent_app_country] => US [patent_app_date] => 2005-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7941 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083981.pdf [firstpage_image] =>[orig_patent_app_number] => 11186497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225268 [patent_doc_number] => 20050255089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'AAV5 nucleic acids' [patent_app_type] => utility [patent_app_number] => 11/184380 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17204 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255089.pdf [firstpage_image] =>[orig_patent_app_number] => 11184380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5767718 [patent_doc_number] => 20060019329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Method of screening for protein inhibitors and activators' [patent_app_type] => utility [patent_app_number] => 11/170465 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15982 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019329.pdf [firstpage_image] =>[orig_patent_app_number] => 11170465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 533200 [patent_doc_number] => 07175998 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Stable Acanthamoeba protein expression systems' [patent_app_type] => utility [patent_app_number] => 11/155446 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 26 [patent_no_of_words] => 8235 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/175/07175998.pdf [firstpage_image] =>[orig_patent_app_number] => 11155446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710294 [patent_doc_number] => 07056699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Lentiviral LTR-deleted vector' [patent_app_type] => utility [patent_app_number] => 11/155043 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 9751 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056699.pdf [firstpage_image] =>[orig_patent_app_number] => 11155043 [rel_patent_id] =>[rel_patent_doc_number] =>)